Atlas Trials

Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma

Clinical trial NCT00317044 · COMPLETED

Trial details

NCT number
NCT00317044
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
AsthmaGERD
Start date
2006-04-01
Primary completion
2008-07-01
Enrollment
961

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.